Diabetes, Dementia, and Oxidative Stress: A look at Nox2-related markers
Official title: Cardiovascular And Dementia Risk in diabeTes Experimental and Clinical Study: Investigation on Nox2- Related Oxidative Stress (CARTESIO).
Run by Neuromed IRCCS · NCT07928453 · Data updated 2026-11-12
This study tests whether oxidative stress linked to Nox2 is related to dementia risk in adults with type 2 diabetes.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 50 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Neuromed IRCCS Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Pozzilli) |
| Status | Recruiting |
| Started | August 31, 2024 |
| Main results expected | January 2027 |
| Study ends | February 28, 2027 |
| Registry record updated | November 10, 2026 |
| Trial ID | NCT07928453 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 50 with established type 2 diabetes, who are either treatment-naive or on one or two oral antidiabetic drugs, and who can provide informed consent.
✕Probably not a fit
Patients with recent acute diabetes complications, very high HbA1c, or recent major cardiovascular events may not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study explores the connection between diabetes, oxidative stress, and dementia risk by examining Nox2-related markers in adults with type 2 diabetes. Participants are adults over 50 with established T2D who meet specific medication and health criteria. The research looks at how oxidative stress might link diabetes duration and vascular or neurodegenerative outcomes, using biomarkers and health data collected under real-world conditions. It is not a treatment trial and does not assign experimental therapies. Findings could clarify potential mechanisms and identify biomarkers for dementia risk in diabetes.
Why it matters
Potential benefit: If successful, the study could help identify biomarkers associated with higher dementia risk in people with diabetes.
How similar studies have gone: Previous work has linked oxidative stress and diabetes to cognitive decline, but this study aims to specifically relate Nox2-related oxidative stress to dementia risk in a diabetes population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Established diagnosis of T2D according to the 2019 ESC guidelines * Written informed consent obtained from the patient before enrollment * Antidiabetic drug-naive, or treated with one or two oral anti-diabetic drugs, or treated with human NPH insulin or longacting insulin analogue or pre-mixed insulin, alone or in combination with one or two oral anti-diabetic drugs * Age \>50 years Exclusion Criteria: * \- Acute decompensation of glycaemic control requiring immediate intensification of treatment to prevent acute complications of diabetes (eg diabetes ketoacidosis) within 90 days prior to screening * HbA1c \>10% * History of chronic pancreatitis or idiopathic acute pancreatitis * History of ischemic stroke or transient ischemic attack * Acute coronary event within 30 days before enrolment * Currently planned coronary, carotid or peripheral artery revascularization * Chronic Heart Failure NYHA Class IV * End-stage liver disease, defined as the presence of acute or chronic liver disease and recent history of one or more of the following: ascites, encephalopathy, variceal bleeding, bilirubin \>2.0 mg/dL, albumin level \<3.5 g/dL, prothrombin time \>4 seconds prolonged, international normalised ratio (INR) \>1.7 or prior liver transplant * End-stage chronic kidney disease (eGFR \<30 ml/min) * Malignant neoplasm requiring chemotherapy, surgery, radiation or palliative therapy in the previous 5 years * Life expectancy \<2 years (and in any case before the completion of the study) * Low adherence to prescribed medications * Female of childbearing potential who is pregnant, breast-feeding or intend to become pregnant or is not using adequate contraceptive methods * Use of oral anticoagulants (atrial fibrillation of venous thromboembolism)
Where it's running
-
Neuromed Irccs
Pozzilli, Italy Recruiting
Study contacts
- Study coordinator: Daniele Pastori, MD, PhD
- Email: daniele.pastori@uniroma1.it
- Phone: 003908659291
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
China HEAD: a large community study on healthy aging and dementia
This study tests whether collecting health, imaging, and biospecimen data from adults in China can help predict who will develop Alzheimer’s disease and related dementias.
-
Doll Therapy for Apathy and Daily Living in Older Adults with Dementia
This study tests whether doll therapy helps reduce apathy and improves starting daily activities in older adults with dementia.
-
Aging Brain Health Initiative in Fujian
This observational study will follow about 3,000 older adults in Fujian to see how Alzheimer's-related changes develop and to test new digital tests, biomarkers, and imaging tools for early diagnosis.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Opioid-Free vs Opioid-Based Anesthesia for Thyroid Surgery
This study tests whether a non-opioid anesthesia approach can match or improve outcomes for adults undergoing thyroidectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.